Search Results - "Shankarraman, Venkat"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Standardized methods to quantify thrombogenicity of blood-contacting materials via thromboelastography by Shankarraman, Venkat, Davis-Gorman, Grace, Copeland, Jack G., Caplan, Michael R., McDonagh, Paul F.

    “…Blood coagulation is the most significant complication of vascular biomaterials. A straightforward, sensitive, and standard measure of the compatibility of…”
    Get full text
    Journal Article
  2. 2

    Biodegradable Zwitterionic Polymer Coatings for Magnesium Alloy Stents by Ye, Sang-Ho, Chen, Yingqi, Mao, Zhongwei, Gu, Xinzhu, Shankarraman, Venkat, Hong, Yi, Shanov, Vesselin, Wagner, William R

    Published in Langmuir (05-02-2019)
    “…Degradable metallic stents, most commonly composed of Mg-based alloys, are of interest as an alternative to traditional metallic stents for application in…”
    Get full text
    Journal Article
  3. 3

    Biodegradable poly(ester urethane)urea elastomers with variable amino content for subsequent functionalization with phosphorylcholine by Fang, Jun, Ye, Sang-Ho, Shankarraman, Venkat, Huang, Yixian, Mo, Xiumei, Wagner, William R.

    Published in Acta biomaterialia (01-11-2014)
    “…[Display omitted] While surface modification is well suited for imparting biomaterials with specific functionality for favorable cell interactions, the…”
    Get full text
    Journal Article
  4. 4

    Nonthrombogenic, Biodegradable Elastomeric Polyurethanes with Variable Sulfobetaine Content by Ye, Sang-Ho, Hong, Yi, Sakaguchi, Hirokazu, Shankarraman, Venkat, Luketich, Samuel K, D’Amore, Antonio, Wagner, William R

    Published in ACS applied materials & interfaces (24-12-2014)
    “…For applications where degradable polymers are likely to have extended blood contact, it is often important for these materials to exhibit high levels of…”
    Get full text
    Journal Article
  5. 5

    Auryon Laser in Treating Symptomatic Infrainguinal Arterial Disease: 1-Year Outcome by Shammas, Nicolas W, Shammas, Gail A, Jones-Miller, Sue, Shankarraman, Venkat, Corbet, Michele B

    Published in The Journal of invasive cardiology (01-07-2022)
    “…The Auryon 355-nm laser atherectomy system (AngioDynamics, Inc) showed a low rate of target-lesion revascularization (TLR) at 6-month follow-up in the…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Hollow Fiber Membrane Modification with Functional Zwitterionic Macromolecules for Improved Thromboresistance in Artificial Lungs by Ye, Sang-Ho, Arazawa, David T, Zhu, Yang, Shankarraman, Venkat, Malkin, Alexander D, Kimmel, Jeremy D, Gamble, Lara J, Ishihara, Kazuhiko, Federspiel, William J, Wagner, William R

    Published in Langmuir (03-03-2015)
    “…Respiratory assist devices seek optimized performance in terms of gas transfer efficiency and thromboresistance to minimize device size and reduce…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Assessment of Thrombelastography and Platelet Life Span in Ovines by Johnson, Carl A., Woolley, Joshua R., Snyder, Trevor A., Shankarraman, Venkat, Haney, Elaine I., Wagner, William R.

    Published in Artificial organs (01-12-2018)
    “…Ovines are a common animal model for the study of cardiovascular devices, where consideration of blood biocompatibility is an essential design criterion. In…”
    Get full text
    Journal Article
  11. 11

    Auryon Laser in Peripheral Arterial Interventions: A Single-Center Experience (Auryon-SCE) by Shammas, Nicolas W, Shammas, Gail A, Halupnik, Grace, Fedele, Nicholas, Comp, Katie, Taleb, Emma-Marie, Jones-Miller, Sue, Shammas, Andrew N, Shankarraman, Venkat

    Published in The Journal of invasive cardiology (01-06-2022)
    “…The Auryon 355-nm laser atherectomy system (AngioDynamics, Inc) showed a low rate of target-lesion revascularization (TLR) at 6-month follow-up in the…”
    Get more information
    Journal Article
  12. 12

    Intracellular signaling controls endothelial cell prostacyclin secretion and regulation of blood clotting time by Shankarraman, Venkat, Davis-Gorman, Grace, McDonagh, Paul F., Caplan, Michael R.

    “…Blood is constantly in contact with a biological material, the blood vessel wall, without the need for anticoagulants to prevent clot formation on the vessel…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Biocompatibility Assessment of the Levitronix® Centrimag® Adult ECMO Circuit in a Model of Acute Pulmonary Hypertension by Shankarraman, Venkat, Kocyildirim, Ergin, Olia, Salim E., Kameneva, Marina V., Dzadony, Ryan J., Maul, Timothy M., Simon, Marc A., Champion, Hunter C., Wagner, William R., Bermudez, Christian A.

    Published in ASAIO journal (1992) (20-03-2014)
    “…Extracorporeal membrane oxygenation (ECMO) is rarely utilized in patients with severe pulmonary hypertension (PH) as a bridge to lung transplantation. In this…”
    Get full text
    Journal Article
  15. 15

    Biocompatibility Assessment of the CentriMag-Novalung Adult ECMO Circuit in a Model of Acute Pulmonary Hypertension by Shankarraman, Venkat, Kocyildirim, Ergin, Olia, Salim E, Kameneva, Marina V, Dzadony, Ryan J, Maul, Timothy M, Simon, Marc A, Champion, Hunter C, Wagner, William R, Bermudez, Christian A

    Published in ASAIO journal (1992) (01-07-2014)
    “…Extracorporeal membrane oxygenation (ECMO) is rarely used in patients with severe pulmonary hypertension (PH) as a bridge to lung transplantation. In this…”
    Get full text
    Journal Article
  16. 16

    Substrates Elicit Different Patterns of Intracellular Signaling Which in Turn Cause Differences in Cell Adhesion by Shankarraman, Venkat, Shah, Miti M., Caplan, Michael R.

    Published in Cellular and molecular bioengineering (01-09-2010)
    “…Although intracellular signal transduction is relatively well understood, how the cells can distinguish among thousands of micro-environments is not. This…”
    Get full text
    Journal Article
  17. 17

    Platelet Activation After Implantation of the Levitronix PediVAS in the Ovine Model by Johnson, Carl A, Shankarraman, Venkat, Wearden, Peter D, Kocyildirim, Ergin, Maul, Timothy M, Marks, John D, Richardson, J. Scott, Gellman, Barry N, Borovetz, Harvey S, Dasse, Kurt A, Wagner, William R

    Published in ASAIO journal (1992) (01-11-2011)
    “…The Levitronix PediVAS is an extracorporeal magnetically levitated pediatric ventricular assist system with an optimal flow rate range of 0.3–1.5 L/min. The…”
    Get full text
    Journal Article
  18. 18

    Platelet Activation Following Implant of the Levitronix PediVAS in the Ovine Model by Johnson, Carl A., Shankarraman, Venkat, Wearden, Peter D., Kocyildirim, Ergin, Maul, Timothy M., Marks, John D., Richardson, J. Scott, Gellman, Barry N., Borovetz, Harvey S., Dasse, Kurt A., Wagner, William R.

    Published in ASAIO journal (1992) (01-01-2011)
    “…The Levitronix PediVAS is an extracorporeal magnetically levitated pediatric ventricular assist system with an optimal flow rate range of 0.3 – 1.5 L/min. The…”
    Get full text
    Journal Article